| Dr Michael Vincent Fanizzi, MD | |
|
123 Mascoma Street, Lebanon, NH 03766 | |
| (603) 448-7464 | |
| Not Available |
| Full Name | Dr Michael Vincent Fanizzi |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 123 Mascoma Street, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174609119 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 8050 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Vincent Fanizzi, MD 1412 Middlebrook Rd, Fairlee, VT 05045-9523 Ph: (802) 333-4156 | Dr Michael Vincent Fanizzi, MD 123 Mascoma Street, Lebanon, NH 03766 Ph: (603) 448-7464 |
News Archive
Results of a UK study published online suggest that the widely practised approach of isolating intensive-care patients infected with MRSA does not reduce cross-infection. Authors of the study caution that this finding should not be extended to general hospital wards, and needs further confirmation from larger studies.
Aastra, a leading provider of IP-Telephony and Contact Center solutions, offers a solution for contact centers needing an alternative for premises-based agents if it is necessary to close the call center due to a disaster or flu epidemic. Aastra's CC:LifeLine™ (www.aastraondemand.com/solutions-cclifeline2.asp) provides a virtual call center environment ensuring that agents can serve customers even if the physical call center is inaccessible.
News outlets report on how the law might affect clinics serving the poor, concerns about scams and details about how the individual mandate will work.
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, and t2cure, a clinical stage biopharmaceutical company developing progenitor cell-based regenerative therapeutics for cardiac or peripheral vascular diseases, announced today that they have entered into a licensing agreement
The effects of Amyloid beta (Aβ)-Aβ-binding alcohol dehydrogenase (ABAD) may exacerbate Alzheimer's disease pathology.
› Verified 4 days ago
Rebecca Anne Frost, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Drive, Lebanon, NH 03756 Phone: 603-650-6150 | |
Alexander S Kloman, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
Dr. Erik J. Kobylarz, MD, PHD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Drive, Dept. Of Neurology, Dartmouth-hitchcock Medical Center, Lebanon, NH 03756 Phone: 603-653-6118 Fax: 603-650-6233 | |
David D Bae, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Dartmouth Hitchcock - Department Of Psychiatry, Lebanon, NH 03756 Phone: 603-650-6150 | |
Robert Joseph Wendling, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 85 Mechanic Street, Suite 360, Adult & Child Services Of Lebanon, Lebanon, NH 03766 Phone: 603-448-1101 Fax: 603-448-8249 | |
Diane M Roston, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 85 Mechanic St, Suite 360 Recovery Center, Lebanon, NH 03766 Phone: 603-448-5610 Fax: 603-448-8260 | |
Amy M Chan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-2967 |